Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Ultragenyx Pharmaceutical Inc. buy Bank of America Co.

Ultragenyx Pharmaceutical Inc.
Start price
€19.80
02.01.26 / 50%
Target price
€49.31
02.01.27
Performance (%)
-2.02%
Price
€19.80
09.01.26
Summary
This prediction is currently active. With a performance of -2.02%, the BUY prediction for Ultragenyx Pharmaceutical Inc. by Bank_of_America_Co_ is down slightly. This prediction currently runs until 02.01.27. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w
Ultragenyx Pharmaceutical Inc. -0.503%
iShares Core DAX® 3.002%
iShares Nasdaq 100 2.966%
iShares Nikkei 225® 5.606%
iShares S&P 500 2.312%

Comments by Bank_of_America_Co_ for this prediction

In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Prediction Buy
Perf. (%) -2.02%
Target price 49.306
Change
Ends at 02.01.27

Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Bank of America Corporation from $72.00 to $58.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat

Bank of America Co. 
0
Report Share
02.01.26

Stopped prediction by Bank_of_America_Co_ for Ultragenyx Pharmaceutical Inc.

buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€37.00
31.05.24
€70.03
31.05.25
-20.00%
01.06.25

Bank of America Co. 
31.05.24 50%